[go: up one dir, main page]

MX2010005280A - Nuevos peptidos sinteticos sustituidos con arginina y su uso. - Google Patents

Nuevos peptidos sinteticos sustituidos con arginina y su uso.

Info

Publication number
MX2010005280A
MX2010005280A MX2010005280A MX2010005280A MX2010005280A MX 2010005280 A MX2010005280 A MX 2010005280A MX 2010005280 A MX2010005280 A MX 2010005280A MX 2010005280 A MX2010005280 A MX 2010005280A MX 2010005280 A MX2010005280 A MX 2010005280A
Authority
MX
Mexico
Prior art keywords
substituted peptides
new synthetic
arginine substituted
synthetic arginine
peptides
Prior art date
Application number
MX2010005280A
Other languages
English (en)
Inventor
Inger Mattsby-Baltzer
Gunnar Dolphin
Original Assignee
Pharmasurgics In Sweden Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmasurgics In Sweden Ab filed Critical Pharmasurgics In Sweden Ab
Publication of MX2010005280A publication Critical patent/MX2010005280A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La presente invención se refiere a nuevos péptidos sustituidos con arginina diseñados con base en la secuencia de lactoferrina humana y al uso de los mismos, en particular para el tratamiento y/o prevención de infecciones, inflamaciones, tumores, dolor, heridas y/o cicatrices.
MX2010005280A 2007-11-14 2008-11-10 Nuevos peptidos sinteticos sustituidos con arginina y su uso. MX2010005280A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07120713A EP2060586A1 (en) 2007-11-14 2007-11-14 New synthetic arginine substituted peptides and their use
US99006607P 2007-11-26 2007-11-26
PCT/EP2008/065186 WO2009062898A1 (en) 2007-11-14 2008-11-10 New synthetic arginine substituted peptides and their use

Publications (1)

Publication Number Publication Date
MX2010005280A true MX2010005280A (es) 2010-08-31

Family

ID=39226731

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010005280A MX2010005280A (es) 2007-11-14 2008-11-10 Nuevos peptidos sinteticos sustituidos con arginina y su uso.

Country Status (9)

Country Link
US (2) US7928185B2 (es)
EP (2) EP2060586A1 (es)
JP (1) JP2011503137A (es)
CN (1) CN101878226B (es)
AU (1) AU2008323041A1 (es)
CA (1) CA2703894A1 (es)
DK (1) DK2212352T3 (es)
MX (1) MX2010005280A (es)
WO (1) WO2009062898A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2481751A1 (en) * 2011-01-26 2012-08-01 PharmaSurgics in Sweden AB Human lactoferrin derived peptides
MX363443B (es) * 2012-12-11 2019-03-21 Osivax Sas Proteinas de tipo espiral enrollada modificadas que tienen propiedades mejoradas.
JP2016520534A (ja) 2013-03-18 2016-07-14 イマクシオＩｍａｘｉｏ インフルエンザ核タンパク質ワクチン
WO2014174517A1 (en) * 2013-04-25 2014-10-30 Carmel-Haifa University Economic Corp. Synthetic anti-inflammatory peptides and use thereof
WO2020096672A1 (en) 2018-11-09 2020-05-14 The Wistar Institute Of Anatomy And Biology Use of lactoferrin for generating myeloid-derived suppressor cells

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2818056B2 (ja) * 1990-09-07 1998-10-30 森永乳業株式会社 抗菌性ペプチドおよび抗菌剤
US5656591A (en) 1992-01-23 1997-08-12 Morinaga Milk Industry Co., Ltd. Antimicrobial agents and method for treating products therewith
JP3347819B2 (ja) 1993-06-28 2002-11-20 森永乳業株式会社 抗菌性ペプチドの精製方法
JP3529423B2 (ja) 1994-04-01 2004-05-24 森永乳業株式会社 抗菌性ペプチドの製造方法
JP3812957B2 (ja) 1994-08-02 2006-08-23 森永乳業株式会社 角膜損傷治療剤
JPH08143468A (ja) 1994-11-17 1996-06-04 Morinaga Milk Ind Co Ltd 抗潰瘍剤
AU3872797A (en) 1996-08-12 1998-03-06 A+ Science Invest Ab Treatment and prevention of infections, inflammations and/or tumours with lactoferrin and/or lactoferricin
SE9804614A0 (en) * 1998-07-06 2000-01-07 A+ Science Invest Ab New peptides and use thereof
US6399570B1 (en) 1999-02-05 2002-06-04 Agennix, Inc. Antimicrobial/endotoxin neutralizing polypeptide
CA2388910C (en) * 1999-11-11 2008-10-07 Am-Pharma B.V. Antimicrobial activity of the first cationic cluster of human lactoferrin
US7183381B2 (en) 2004-10-26 2007-02-27 Agennix, Inc. Composition of lactoferrin related peptides and uses thereof

Also Published As

Publication number Publication date
JP2011503137A (ja) 2011-01-27
EP2060586A1 (en) 2009-05-20
CN101878226A (zh) 2010-11-03
US20090186823A1 (en) 2009-07-23
EP2212352A1 (en) 2010-08-04
US7928185B2 (en) 2011-04-19
US20110224152A1 (en) 2011-09-15
WO2009062898A1 (en) 2009-05-22
CN101878226B (zh) 2014-06-25
DK2212352T3 (da) 2014-09-29
EP2212352B1 (en) 2014-07-02
AU2008323041A1 (en) 2009-05-22
US8815812B2 (en) 2014-08-26
CA2703894A1 (en) 2009-05-22

Similar Documents

Publication Publication Date Title
MX2013007995A (es) Peptidos derivados de lactoferrina humana y su uso.
PH12013500867A1 (en) Dual variable domain immunoglobulins and uses thereof
NZ603200A (en) Peptides and their use
PH12013500337A1 (en) Dual variable domain immunoglobulins and uses thereof
PH12013500207A1 (en) Dual variable domain immunoglobulins and uses thereof
PH12015500186A1 (en) Combination therapies for melanoma comprising administering cobimetinib and vemurafinib
UA105290C2 (ru) АПТАМЕРЫ К β-NGF И ИХ ПРИМЕНЕНИЕ ПРИ ЛЕЧЕНИИ β-NGF-ОПОСРЕДОВАННЫХ ЗАБОЛЕВАНИЙ И РАССТРОЙСТВ
GB201001602D0 (en) Oligopeptidic compounds and uses therof
ZA201304638B (en) Composition for use in the prevention and /or treatment of skin condition and skin diseases.
PH12014502537A1 (en) Therapeutic uses of fibroblast growth factor 21 proteins
PH12012502523A1 (en) Dual variable domain immunoglobulins and uses thereof
IN2012DN03310A (es)
MY184241A (en) Human antibodies to gfr?3 and methods of use thereof
MY158325A (en) Multitype peptide compositions and methods for treatment or prevention of human papillpmavirus infection
SG191060A1 (en) Robo1-fc fusion protein for use in the treatment of hepatocarcinoma
MX2010005280A (es) Nuevos peptidos sinteticos sustituidos con arginina y su uso.
WO2015084883A3 (en) Compositions and methods for treating osteoarthritis
GB201003559D0 (en) Novel use of elafin
WO2009033819A3 (en) Use of glicentin-related polypeptide and apelin- 13 in combination as therapeutic agents, eg for treating aids
WO2009083249A3 (en) Synthetic analogs of human beta-defensins having antimicrobial, antiviral and chemotactic activity
WO2011163512A3 (en) Cancer therapy
WO2011091154A3 (en) Use of human erythrocytes for prevention and treatment of cancer dissemination and growth
NZ598124A (en) Compounds for treatment of inflammation
WO2009074253A3 (en) Clofarabine dietherphospholipid derivatives
ATE489947T1 (de) Axomadol zur schmerzbehandlung bei arthrose

Legal Events

Date Code Title Description
FG Grant or registration
GB Transfer or rights